During the two decades I’ve had Crohn’s disease, I’ve been on lots of different medications. But an infusion — a biologic that’s given intravenously — can seem particularly daunting, especially if you ...
Remicade (infliximab) is a prescription drug that’s used to manage certain autoimmune conditions in adults and some children. The drug is usually given as an intravenous (IV) infusion every 8 weeks.
Tysabri (natalizumab) is a prescription drug that’s used to treat multiple sclerosis (MS), clinically isolated syndrome (CIS), and Crohn’s disease. Tysabri comes as an intravenous (IV) infusion (an ...
I'm fortunate to work as a gastroenterologist at a time when we have many excellent options for treating Crohn's disease, including new biologic and small-molecule drugs. The number of new treatments ...
Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...
https://www.tipranks.com/news/the-fly/evofem-says-fda-orange-book-lists-patent-for-solosec-treatment-thefly The U.K.’s Medicines and Healthcare products Regulatory ...
DANVILLE, Pa. — Saige LaCoe is a typical 14-year-old girl who loves to dance. But six years ago, bad stomach pains slowed her down. After many tests and a colonoscopy, Saige was diagnosed with Crohn's ...
The EVOLVE study was a retrospective chart review of real-world data in biologic-naïve patients with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD) treated with ...
Bhat: I love this question! Crohn’s disease treatment has progressed significantly in recent years, incorporating new mechanisms of action such as interleukin inhibitors and Janus kinase inhibitors.
I began having Crohn's disease symptoms of as far back as age 13 or 14. At the time, I tried to hide my condition. The teenage years are already awkward. The last thing I wanted was for my friends and ...
A multiple sclerosis drug that was pulled from the market for safety reasons has shown some effectiveness against the painful bowel disorder Crohn’s disease, researchers say. Tysabri did not work very ...